These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 34445587)
1. PLGA/PLA-Based Long-Acting Injectable Depot Microspheres in Clinical Use: Production and Characterization Overview for Protein/Peptide Delivery. Butreddy A; Gaddam RP; Kommineni N; Dudhipala N; Voshavar C Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445587 [TBL] [Abstract][Full Text] [Related]
2. Quality by design thinking in the development of long-acting injectable PLGA/PLA-based microspheres for peptide and protein drug delivery. Zhang C; Yang L; Wan F; Bera H; Cun D; Rantanen J; Yang M Int J Pharm; 2020 Jul; 585():119441. PubMed ID: 32442645 [TBL] [Abstract][Full Text] [Related]
3. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications. Ma G J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676 [TBL] [Abstract][Full Text] [Related]
4. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres. Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463 [TBL] [Abstract][Full Text] [Related]
5. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules. Abulateefeh SR; Alkawareek MY; Alkilany AM Int J Pharm; 2019 Mar; 558():291-298. PubMed ID: 30641178 [TBL] [Abstract][Full Text] [Related]
6. Effect of mPEG-PLGA on Drug Crystallinity and Release of Long-Acting Injection Microspheres: In Vitro and In Vivo Perspectives. Xing D; Tang L; Yang H; Yan M; Yuan P; Wu Y; Zhang Y; Yin T; Wang Y; Gou J; Tang X; He H Pharm Res; 2024 Jun; 41(6):1271-1284. PubMed ID: 38839720 [TBL] [Abstract][Full Text] [Related]
7. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System. Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642 [TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres. Kostanski JW; Thanoo BC; DeLuca PP Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259 [TBL] [Abstract][Full Text] [Related]
9. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Prior S; Gamazo C; Irache JM; Merkle HP; Gander B Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713 [TBL] [Abstract][Full Text] [Related]
10. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres. Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338 [TBL] [Abstract][Full Text] [Related]
11. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Blanco D; Alonso MJ Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633 [TBL] [Abstract][Full Text] [Related]
12. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid). Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055 [TBL] [Abstract][Full Text] [Related]
13. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide. Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres. Xu FH; Zhang Q Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799 [TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Woo BH; Jiang G; Jo YW; DeLuca PP Pharm Res; 2001 Nov; 18(11):1600-6. PubMed ID: 11758769 [TBL] [Abstract][Full Text] [Related]
17. Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres. Li T; Chandrashekar A; Beig A; Walker J; Hong JKY; Benet A; Kang J; Ackermann R; Wang Y; Qin B; Schwendeman AS; Schwendeman SP Eur J Pharm Biopharm; 2021 Jan; 158():401-409. PubMed ID: 33122118 [TBL] [Abstract][Full Text] [Related]
18. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics. Shao PG; Bailey LC Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912 [TBL] [Abstract][Full Text] [Related]
19. Dry fabrication of poly(dl-lactide-co-glycolide) microspheres incorporating a medium molecular drug by a ball mill method. Matsumoto A; Murakami M Drug Discov Ther; 2021 Mar; 15(1):20-27. PubMed ID: 33627576 [TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. Blanco-Príeto MJ; Besseghir K; Zerbe O; Andris D; Orsolini P; Heimgartner F; Merkle HP; Gander B J Control Release; 2000 Jun; 67(1):19-28. PubMed ID: 10773325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]